Palo Alto Investors’s Minerva Neurosciences NERV Stock Holding History

Palo Alto Investors’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,540	Closed	-$63K	–	38
2021 Q3	$63K	Hold	4,540	–	–	﹤0.01%	42
2021 Q2	$84K	Hold	4,540	–	–	﹤0.01%	42
2021 Q1	$106K	Hold	4,540	–	–	0.01%	41
2020 Q4	$85K	Hold	4,540	–	–	﹤0.01%	41
2020 Q3	$115K	Hold	4,540	–	–	0.01%	43
2020 Q2	$131K	Hold	4,540	–	–	0.01%	41
2020 Q1	$219K	Hold	4,540	–	–	0.02%	35
2019 Q4	$258K	Hold	4,540	–	–	0.01%	34
2019 Q3	$281K	Hold	4,540	–	–	0.02%	33
2019 Q2	$204K	Buy	+4,540	New	+$227K	0.01%	37

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Palo Alto Investors's NERV Position: Q4 2021 in Review

Palo Alto Investors sold out of Minerva Neurosciences (NERV) in Q4 2021, closing a stake of 4,540 shares — an estimated $63K sold.

Palo Alto Investors first reported a position in NERV in Q2 2019 and held it in 10 quarters. The position peaked at $281K in Q3 2019. 35 funds tracked by Wall St. Rank hold NERV as of Q4 2021.

Palo Alto Investors reported no remaining Minerva Neurosciences position as of Q4 2021 after selling out during the quarter.
Palo Alto Investors sold 4,540 Minerva Neurosciences shares in Q4 2021, an estimated $63K.
Palo Alto Investors first reported a position in Minerva Neurosciences in Q2 2019 and held it in 10 quarters.
Palo Alto Investors's Minerva Neurosciences position peaked at $281K in Q3 2019.
35 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2021.

Based on Palo Alto Investors's 13F filing for Q4 2021, filed 14 Feb 2022.